Markets:

Overview

News

Currencies

International

Treasuries

Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

May 15, 2024

AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023 ↗

March 29, 2024

AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Agile Therapeutics: Q4 Earnings Insights ↗

March 28, 2024

Via Benzinga

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

March 28, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics's Earnings: A Preview ↗

March 27, 2024

Via Benzinga

Agile Therapeutics's Earnings: A Preview ↗

March 21, 2024

Via Benzinga

Why Agile Therapeutics (AGRX) Stock Is Down 60% ↗

March 26, 2024

Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 25, 2024

Via Benzinga

Agile Therapeutics Announces Delisting from Nasdaq

March 25, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For March 22, 2024 ↗

March 22, 2024

Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million.

Via Benzinga

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

March 21, 2024

Live Conference Call and Webcast at 8:30 a.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

March 20, 2024

Live Conference Call and Webcast at 8:30 a.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 13, 2024

Via Benzinga

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution

March 13, 2024

Elimination of Remaining Debt to Perceptive Advisors Leaves the Company’s Balance Sheet Debt Free

From Agile Therapeutics, Inc.

Via GlobeNewswire

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

What's Going On With Women Health Focused Agile Therapeutics Stock Today? ↗

February 22, 2024

Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share.

Via Benzinga

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

February 22, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

Why Is Bel Fuse (BELFB) Stock Down 17% Today? ↗

February 22, 2024

Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report.

Via InvestorPlace

Why Is Draganfly (DPRO) Stock Down 48% Today? ↗

February 22, 2024

Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares.

Via InvestorPlace

Why Is BuzzFeed (BZFD) Stock Up 101% Today? ↗

February 22, 2024

BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

Why Is Agile Therapeutics (AGRX) Stock Up 87% Today? ↗

February 22, 2024

Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company.

Via InvestorPlace

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

February 22, 2024

Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 22, 2024

Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning!

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

February 19, 2024

Via Benzinga

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update

February 15, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost

January 23, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

A Look Into Healthcare Sector Value Stocks ↗

January 22, 2024

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

January 15, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.